You are here

FTLV AS A SMALL LABORATORY MODEL OF HIV

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 11056
Amount: $475,455.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1990
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
100 Fore St
Portland, ME 04101
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THE LONG-TERM OBJECTIVES OF THIS PROJECT ARE TO DEVELOP METHODOLOGIES AND A KNOWLEDGE BASE THAT WILL ENHANCE THE UTILIZATION OF FELINE T-CELL LYMPHOTROPIC LENTIVIRUS (FTLV) AS A SMALL-LABORATORY ANIMAL MODEL OF HIV. IN PHASE I, A FTLV ANTIGEN TEST WILL BE DEVELOPED THAT WILL AUGMENT EXISTING ANTIBODY TESTS AND PROVIDE VETERINARIANS AND RESEARCH SCIENTISTS WITH DIAGNOSTIC TOOLS TO MONITOR FTLV INFECTION. IT IS ALSO PLANNED TO BEGIN NUCLEIC ACID SEQUENCE ANALYSIS OF FTLV TO OBTAIN A BETTER UNDERSTANDING OF THE GENOMIC ORGANIZATION OF THIS VIRUS AND TO COMPARE THESE RESULTS WITHTHE KNOWN SEQUENCE OF HIV AND OTHER LENTIVIRUSES. THE FTLV MODEL POSSESSES ADVANTAGES FOR THE DEVELOPMENT OF DRUGS TO BLOCK LENTIVIRUS REPLICATION AND TO EVALUATE A PARTICULAR APPROACH IN THE DEVELOPMENT OF LENTIVIRUS VACCINES.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government